Surgical Science Sweden AB (publ) (SUSRF) Research

Surgical Science Sweden AB (publ) specializes in the creation and distribution of advanced virtual reality (VR) simulation platforms. These systems are engineered to provide evidence-based training for both laparoscopic and endoscopic surgical procedures. Their extensive product lineup features the LapSim training system, which includes LapSim ST, specifically designed for educating surgical technologists and assistants, and LapSim essence, a compact and readily deployable VR simulator. The company further offers the EndoSim system, an endoscopy simulator that delivers realistic medical simulation experiences. Additionally, they provide TeamSim, a dynamic platform that promotes inter-professional education by integrating surgical simulation into practical team-based scenarios. Other offerings encompass the Simball Box, which supplies velocity feedback along with instructional videos demonstrating preferred techniques, as well as their range of Simbionix and robotic surgery simulators. Founded in 1999, Surgical Science AB maintains its primary operations in Gothenburg, Sweden.

Market snapshot

Symbol
SUSRF
Price
$4.00
Day change
0.00%
Market cap
$1.6B
P/E ratio
30.10x
52-week range
2.84-15.471
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Next earnings
in 2 months

Peer companies

  • Avacta Group Plc (AVCTF)
  • BioInvent International AB (publ) (BOVNF)
  • COLTENE Holding AG (CLHLF)
  • Cogstate Limited (COGZF)
  • Hua Medicine (Shanghai) Ltd. (HUMDF)
  • Knight Therapeutics Inc. (KHTRF)
  • Kneat.com, Inc. (KSIOF)
  • PureTech Health plc (PTCHF)

Open Surgical Science Sweden AB (publ) (SUSRF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.